Clinical Trial Update: Recombinant Human Erythropoietin Compared to Autologous Pre-Donation Prior to Scoliosis Surgery in Children. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing recombinant human erythropoietin with autologous pre-donation before scoliosis surgery in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scoliosis

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: University of British Columbia | Conditions: Scoliosis | Phase 3 | Status: COMPLETED